Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 15 October 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Although the dental distribution business (株式会社ASANO) increased net sales, its original gross profit margin was low, and measures to reduce the cost ratio remain in the post-merger integration (PMI) phase, weighing on consolidated profit. In addition, following a review of the recoverability of deferred tax assets, the Company expects to reverse deferred tax assets and recognize income taxes—deferred (loss). On a standalone basis, growth in the medical platform business continued to slow in the first half due to sluggish growth in page views. Although the business has entered a recovery trend, the Company does not expect to make up for the stagnation over the full year.
| Item | Details |
|---|---|
| Net Sales | Consolidated 11,332 / Individual 11,261 → Consolidated 11,565 / Individual 8,686（Consolidated 2.1 / Individual -22.9） |
| Operating profit | Consolidated 477 → Consolidated 400（Consolidated -16.1） |
| Ordinary income | Consolidated 482 / Individual 1,396 → Consolidated 432 / Individual 556（Consolidated -10.3 / Individual -60.1） |
| Profit attributable to owners of the parent | Consolidated 417 / Standalone (net income) 953 → Consolidated 275 / Standalone (net income) 314（Consolidated -34 / Standalone (net income) -67） |
| Net income per share | Consolidated 24.11 / Individual 55.09 → Consolidated 15.89 / Individual 18.15 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 15 October 2025 |
| Previous-period results | Consolidated: net sales of ¥10,006 million, operating profit of ¥2,026 million, ordinary profit of ¥2,018 million, net income attributable to owners of the parent of ¥1,413 million, and consolidated earnings per share of ¥79.78. Standalone: net sales of ¥9,850 million, ordinary profit of ¥2,032 million, net income of ¥1,429 million, and earnings per share of ¥80.71 (fiscal year ended March 2025) |
| Reason for the revision | Although the dental distribution business (株式会社ASANO) increased net sales, its original gross profit margin was low, and measures to reduce the cost ratio remain in the post-merger integration (PMI) phase, weighing on consolidated profit. In addition, following a review of the recoverability of deferred tax assets, the Company expects to reverse deferred tax assets and recognize income taxes—deferred (loss). On a standalone basis, growth in the medical platform business continued to slow in the first half due to sluggish growth in page views. Although the business has entered a recovery trend, the Company does not expect to make up for the stagnation over the full year. |
| Dividend forecast revision | The initial forecast of ¥30 per share is expected to be maintained |
| Consolidated / non-consolidated | Consolidated/non-consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.On a consolidated basis, the dental distribution business acquired in July 2025 had a low gross profit margin, and measures to reduce the cost ratio remain in the post-merger integration (PMI) phase, which weighed on profit. In addition, following a review of the recoverability of deferred tax assets, the Company expects to reverse deferred tax assets and recognize income taxes—deferred (loss). On a standalone basis, growth in the core medical platform business has continued to slow due to sluggish growth in page views. Although the business has recently recovered, the Company does not expect to make up for the stagnation in the first half over the full year.